Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better

被引：0

作者：

Mannucci, Pier Mannuccio ^{[1
]}

机构：

[1] Mangiagalli & Regina Elena Fdn, IRCCS Maggiore Hosp, Sci Direct, Milan, Italy

来源：

BLOOD TRANSFUSION | 2010年 / 8卷 / 04期

关键词：

VON-WILLEBRAND-FACTOR; PREVIOUSLY UNTREATED PATIENTS; INHIBITOR DEVELOPMENT; RISK-FACTORS; IN-VITRO; PRODUCTS; EPIDEMIOLOGY; ANTIBODIES; RELEVANCE; PROTECTS;

D O I：

10.2450/2010.0072.10

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：288 / 291

页数：4

共 50 条

[41] Interferon-gamma secretion defects in haemophilia A patients receiving highly purified plasma-derived or recombinant factor VIII
NewtonNash, DK
Tollerud, D
Guevarra, L
Gill, JC
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (03) : 554 - 560
[42] TRANSMISSION OF HUMAN PARVOVIRUS B19 BY PLASMA-DERIVED FACTOR-VIII CONCENTRATES
LAURIAN, Y
DUSSAIX, E
PARQUET, A
CHALVONDEMERSAY, A
DOIRON, R
TCHERNIA, G
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1994, 36 (06): : 449 - 453
[43] Biological and biochemical assays to ensure the quality and safety of plasma-derived products: Factor VIII concentrates
Radosevich, Miryana
Burnouf, Thierry
CURRENT PHARMACEUTICAL ANALYSIS, 2007, 3 (02) : 83 - 94
[44] RECOMBINANT AND PLASMA-DERIVED FACTOR-VIII ARE IMMUNOLOGICALLY DISTINCT IN IN-VITRO ASSAYS
GILLES, JGG
SAINTREMY, JMR
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1213 - 1213
[45] VIRAL SAFETY ISSUES - PLASMA-DERIVED FACTOR-VIII
BERNTORP, E
ANNALS OF HEMATOLOGY, 1994, 68 : S35 - S36
[46] ADAMTS13 Content of Plasma-Derived Factor VIII-Von Willebrand Factor Concentrates
Peyvandi, Flora
Mannucci, Pier Mannuccio
Valsecchi, Carla
Pontiggia, Silvia
Bernstein, Jonathan
Guazzini, Stefano
Retzios, Anastassios
BLOOD, 2012, 120 (21)
[47] A Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (Wilate)
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1340): : 45 - 46
[48] High-purity, plasma-derived, pasteurized Factor VIII concentrates in the treatment of patients with haemophilia A: update of a long-term pharmacovigilance study
Klamroth, Robert
Holzhauer, Susanne
Heller, Christine
Sommerer, Patrick
Kurnik, Karin
HAEMOPHILIA, 2014, 20 : 24 - 24
[49] The safety of plasma-derived haemophilia factor concentrates - comments on "Deep viral metagenomics in patients with haemophilia receiving plasma-derived coagulation factor concentrates" Nunes Valenca I et al. (2021). Deep viral metagenomics in patients with haemophilia receiving plasma-derived coagulation factor concentrates. Haemophilia. https://doi.org/10.1111/hae.14382
Farrugia, Albert
HAEMOPHILIA, 2021, 27 (06) : E760 - E761
[50] PLASMA-DERIVED VERSUS RECOMBINANT HEPATITIS-B VACCINES
KURTZ, JB
ALDER, MJ
MAYONWHITE, RT
JUELJENSEN, BE
RODGERS, TM
BABIC, GM
LANCET, 1989, 1 (8635): : 451 - 451

← 1 2 3 4 5 →